Cart
sales@molnova.com
Swertiachoside B
CAS No. 1831153-21-9
Swertiachoside B( ——— )
Catalog No. M39664 CAS No. 1831153-21-9
Swertiachoside B
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSwertiachoside B
-
NoteResearch use only, not for human use.
-
Brief DescriptionSwertiachoside B
-
DescriptionSwertiachoside B
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1831153-21-9
-
Formula Weight426.374
-
Molecular FormulaC19H22O11
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
FFAGLDD TFA
FFAGLDD TFA is an MMP9 selective cleavage peptide, which is used for the cytoplasmic transfer of doxorubicin (DOX) to realize the controlled slow drug delivery and release.
-
Acetyl-(Cys4,D-Phe7,...
Acetyl-(Cys4,D-Phe7,Cys10)-α-MSH (4-13)
-
Sotrovimab
Sotrovimab (VIR 7831) is a monoclonal antibody against the SARS-CoV-2 virus that causes COVID-19.
